English
INNOCAN PHARMA CORPORATION
EDGARMarket value is not computed: no listed ticker is recorded for this company.
2 filing records in this dataset, filed from 2025-07-23 to 2026-03-16. Explore the available filing history and original sources.
Holdings and insider activity
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-16; this is not a statement that none were filed.
Registration statement
This company has filed to register securities with the SEC and has not yet filed an annual or quarterly report. Its financial statements are in the filing itself rather than structured data, so reported figures appear here once periodic reports are filed.
- Registration statement for a foreign issuer (F-1) · filed 2026-03-16 Open filing documents
- Registration statement for a foreign issuer (F-1) · filed 2025-07-23 Open filing documents
Offering terms · F-1 · 2026-03-16
- Security
- Units consisting of: (i) Ordinary shares, no par value (ii) Common Warrants to purchase ordinary shares
- Maximum offering price
- USD 25,875,000
- Registration fee
- USD 3,573.34 · 0.0138%
- Security
- Pre-Funded Units consisting of: (i) Pre-Funded Warrants to purchase ordinary shares (ii) Common Warrants to purchase ordinary shares
- Maximum offering price
- USD 0
- Registration fee
- USD 0 · 0.0138%
- Security
- Representative's Warrants
- Maximum offering price
- USD 0
- Registration fee
- USD 0 · 0.0138%
- Security
- Ordinary shares issuable upon exercise of the common warrants
- Maximum offering price
- USD 32,343,750
- Registration fee
- USD 4,466.67 · 0.0138%
- Security
- Ordinary shares issuable upon exercise of the pre-funded warrants
- Maximum offering price
- USD 0
- Registration fee
- USD 0 · 0.0138%
- Security
- Ordinary shares issuable upon exercise of the Representative's Warrants
- Maximum offering price
- USD 1,617,187.5
- Registration fee
- USD 223.33 · 0.0138%
Offering terms · F-1 · 2025-07-23
- Security
- Units consisting of:
- Maximum offering price
- USD 17,250,000
- Registration fee
- USD 2,640.98 · 0.0153%
- Security
- (i) Common shares, no par value
- Maximum offering price
- USD 0
- Registration fee
- USD 0 · 0.0153%
- Security
- (ii) Common Warrants to purchase common shares
- Maximum offering price
- USD 0
- Registration fee
- USD 0 · 0.0153%
- Security
- Representative's Warrants
- Maximum offering price
- USD 0
- Registration fee
- USD 0 · 0.0153%
- Security
- Common shares issuable upon exercise of the common warrants
- Maximum offering price
- USD 21,562,500
- Registration fee
- USD 3,301.22 · 0.0153%
- Security
- Ordinary shares issuable upon exercise of the Representative's Warrants
- Maximum offering price
- USD 1,078,125
- Registration fee
- USD 165.1 · 0.0153%
The maximum offering price is the amount the registration fee is computed on, not what the company expects to raise. The offering size and price range are in the prospectus.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
2 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001889791, 1889791, edgar:1889791
Also known as INNOCAN PHARMA CORPORATION, INNOCAN PHARMA Corp